Current guidance for medical journals allows industry input to remain hidden, critic says
International guidelines for medical journals are too lax and enable drug companies to conceal their contributions to scientific papers, says a personal view published in PLoS Medicine…
http://feeds.bmj.com/~r/bmj/recent/~3/-wFpmLG-yO0/bmj.d5132.short